Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration

The Defense Logistics Agency Troop Support Medical is procuring Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration through solicitation SPE2DP-25-R-0001. This indefinite delivery, indefinite quantity (IDIQ) contract requires FDA approval to sell the vaccine prior to award, with non-manufacturers needing to submit a letter of commitment from the manufacturer. The vaccines must be refrigerated between 2-8 degrees Celsius, maintain at least 12 months of expiration dating at delivery, and be delivered monthly to various military medical facilities. Pricing evaluation will be conducted by multiplying the unit price for each contract line item by the annual maximum quantity of 2,300 packages. The amended solicitation deadline is November 7, 2025 at 3:00 PM EST, with offers required electronically via the DLA Internet Bid Board System (DIBBS). The government intends to award without discussions but reserves the right to conduct clarifications if necessary.

This procurement does not utilize any set-aside designations and no current incumbents or contractors are identified in the documentation. The contract structure includes a one-year base period with four one-year option periods, creating a maximum five-year ordering period. The estimated annual quantity is 2,000 packages with a guaranteed minimum of 1,500 packages per year and a maximum of 2,300 packages annually, where each package contains two bottles of 100 tablets each for Type 4 and Type 7 vaccines. Performance will occur within the United States, with deliveries scheduled monthly to various military medical facilities. The solicitation falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and PSC category 6505 for Drugs and Biologicals.